Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Gastroenterology. 2022 Mar 10;162(7):1990–2003. doi: 10.1053/j.gastro.2022.03.004

Table 1.

Baseline Demographic and Clinical Data

Controls (n=10) NAFLD (n=37) p-value
Age (years) 33 (11.7) 51 (12.0) <0.0001
Sex - (female %) 4 (40%) 20 (54%) 0.49
Ethnicity [n (%)]
 Caucasian 5 (50%) 17 (46%) 0.009
 Hispanic 0 (0%) 14 (38%)
 African-American 3 (30%) 1 (3%)
 Other 2 (20%) 5 (13%)
BMI (kg/m 2 ) 21.8 (2.0) 33.3 (5.5) <0.0001
ALT (U/L) 16 (7.7) 62 (54) <0.0001
HbA1C (%) 5.3 (0.3) 5.9 (0.9) 0.03
Fasting glucose (mg/dL) 89 (5.2) 108 (21.6) <0.0001
Fasting Insulin (mcU/mL) 7.9 (5.3) 23.9 (9.6) <0.0001
HOMA-IR 1.8 (1.2) 6.5 (3.2) <0.0001
Triglycerides (mg/dL) 61 (18) 171 (70) <0.0001
Waist circumference (cm) 77.4 (5.6) 108.4 (13.4) <0.0001
Percent Fat (%) 24 (8.7) 40 (7.4) <0.0001
Fat mass (kg) 14.6 (4.8) 37.0 (12.9) <0.0001
Lean mass (kg) 44.9 (10.4) 51.3 (10.1) 0.09
Fat Free Mass (kg) 47.5 (10.9) 53.9 (10.5) 0.10
Visceral Adipose Tissue volume (cm 3 ) 256 (127) 2257 (1114) <0.0001
Baseline Energy Expenditure (kcal/min) a 1.57 (0.47) 1.88 (0.33) 0.03
Baseline Respiratory Quotient A 0.87 (0.02) 0.89 (0.04) 0.12
Postprandial Change in Respiratory Quotient 0.08 (0.26) −0.01 (0.03) 0.31
Mixed Meal Dose (kCal) 613 (101) 683 (127) 0.11

Demographic and clinical characteristics are presented as mean (SD) unless otherwise stated.

A

n=9 Controls and n=36 NAFLD